Emergency Room Wait Times
Home > Clinical Trials > Clinical Trial Details
<< Back to Results
Request Additional Trial InformationFull Trial Details: ClinicalTrials.gov
Condition: Breast CancerStudy Type: Interventional Phase: Phase IIStudy Start Date: 05/01/2014Study Completion Date: 01/31/2018
This is a study to determine the safety and effectiveness of BKM120 plus capecitabine in breast cancer patients with brain metastases. Both capecitabine and BMK120 have previously shown acivity in patients with breast cancer. Like capecitabine, BMK120 is also effective in crossing the blood brain barrier making it a preferred candidate for its evaluation in patients with metastatic breast cancer(MBC).
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.